Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8 |
Intermediate Similarity |
NPD5080 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD5079 |
Phase 2 |
0.7928 |
Intermediate Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD6840 |
Approved |
0.7788 |
Intermediate Similarity |
NPD2876 |
Phase 3 |
0.7788 |
Intermediate Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.7717 |
Intermediate Similarity |
NPD2824 |
Phase 2 |
0.7658 |
Intermediate Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD2902 |
Phase 2 |
0.754 |
Intermediate Similarity |
NPD7273 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD4458 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD4716 |
Approved |
0.7415 |
Intermediate Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD8250 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.7364 |
Intermediate Similarity |
NPD6992 |
Phase 2 |
0.7336 |
Intermediate Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD4187 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD2451 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD2450 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD2452 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD2453 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD4612 |
Discontinued |
0.7224 |
Intermediate Similarity |
NPD6351 |
Discovery |
0.7209 |
Intermediate Similarity |
NPD7138 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD1915 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD4495 |
Phase 1 |
0.7175 |
Intermediate Similarity |
NPD5486 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2544 |
Clinical (unspecified phase) |
0.7137 |
Intermediate Similarity |
NPD6036 |
Suspended |
0.7105 |
Intermediate Similarity |
NPD8321 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD207 |
Discontinued |
0.7082 |
Intermediate Similarity |
NPD537 |
Phase 2 |
0.7082 |
Intermediate Similarity |
NPD534 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD5458 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD34 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD4714 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.7054 |
Intermediate Similarity |
NPD6307 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD9582 |
Phase 3 |
0.7028 |
Intermediate Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD6381 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD4080 |
Discontinued |
0.6955 |
Remote Similarity |
NPD4654 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD4896 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD5171 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD6326 |
Phase 2 |
0.6942 |
Remote Similarity |
NPD4306 |
Phase 1 |
0.6935 |
Remote Similarity |
NPD7486 |
Phase 1 |
0.6912 |
Remote Similarity |
NPD339 |
Approved |
0.6899 |
Remote Similarity |
NPD6023 |
Discontinued |
0.6878 |
Remote Similarity |
NPD4414 |
Discontinued |
0.6875 |
Remote Similarity |
NPD6327 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD8291 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD338 |
Approved |
0.6862 |
Remote Similarity |
NPD5703 |
Discontinued |
0.6858 |
Remote Similarity |
NPD4599 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD6573 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD6572 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD3590 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD1273 |
Discontinued |
0.6826 |
Remote Similarity |
NPD796 |
Phase 2 |
0.6822 |
Remote Similarity |
NPD5949 |
Phase 3 |
0.6811 |
Remote Similarity |
NPD8442 |
Discontinued |
0.68 |
Remote Similarity |
NPD8375 |
Approved |
0.6796 |
Remote Similarity |
NPD169 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD3343 |
Phase 3 |
0.6787 |
Remote Similarity |
NPD4440 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6781 |
Remote Similarity |
NPD2540 |
Clinical (unspecified phase) |
0.6777 |
Remote Similarity |
NPD7988 |
Suspended |
0.6765 |
Remote Similarity |
NPD283 |
Approved |
0.6761 |
Remote Similarity |
NPD2414 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD6605 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD1197 |
Approved |
0.675 |
Remote Similarity |
NPD7202 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD8371 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD5644 |
Phase 1 |
0.6744 |
Remote Similarity |
NPD7706 |
Clinical (unspecified phase) |
0.6737 |
Remote Similarity |
NPD6958 |
Approved |
0.6737 |
Remote Similarity |
NPD6711 |
Approved |
0.6737 |
Remote Similarity |
NPD6957 |
Approved |
0.6719 |
Remote Similarity |
NPD5911 |
Clinical (unspecified phase) |
0.6712 |
Remote Similarity |
NPD7504 |
Discontinued |
0.6711 |
Remote Similarity |
NPD2536 |
Discontinued |
0.6709 |
Remote Similarity |
NPD6763 |
Discontinued |
0.6709 |
Remote Similarity |
NPD4563 |
Phase 2 |
0.6708 |
Remote Similarity |
NPD1571 |
Phase 2 |
0.6707 |
Remote Similarity |
NPD6970 |
Phase 2 |
0.6699 |
Remote Similarity |
NPD242 |
Approved |
0.6697 |
Remote Similarity |
NPD5757 |
Discontinued |
0.6696 |
Remote Similarity |
NPD1234 |
Discontinued |
0.6696 |
Remote Similarity |
NPD2127 |
Suspended |
0.6695 |
Remote Similarity |
NPD6856 |
Discontinued |
0.6692 |
Remote Similarity |
NPD7198 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3403 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6653 |
Remote Similarity |
NPD8004 |
Discontinued |
0.6653 |
Remote Similarity |
NPD7068 |
Approved |
0.6653 |
Remote Similarity |
NPD7067 |
Approved |
0.6627 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.6626 |
Remote Similarity |
NPD7051 |
Phase 3 |
0.6626 |
Remote Similarity |
NPD7050 |
Clinical (unspecified phase) |
0.6626 |
Remote Similarity |
NPD6352 |
Phase 2 |
0.6626 |
Remote Similarity |
NPD1572 |
Phase 2 |
0.6622 |
Remote Similarity |
NPD706 |
Phase 1 |
0.6622 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.662 |
Remote Similarity |
NPD247 |
Clinical (unspecified phase) |
0.662 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6617 |
Remote Similarity |
NPD6175 |
Phase 3 |
0.66 |
Remote Similarity |
NPD4858 |
Phase 2 |
0.6598 |
Remote Similarity |
NPD2349 |
Phase 3 |
0.6597 |
Remote Similarity |
NPD6643 |
Discontinued |
0.6589 |
Remote Similarity |
NPD8373 |
Clinical (unspecified phase) |
0.6588 |
Remote Similarity |
NPD6244 |
Phase 3 |
0.6588 |
Remote Similarity |
NPD6243 |
Phase 3 |
0.6584 |
Remote Similarity |
NPD4403 |
Phase 3 |
0.6584 |
Remote Similarity |
NPD4401 |
Phase 2 |
0.6579 |
Remote Similarity |
NPD691 |
Discontinued |
0.6574 |
Remote Similarity |
NPD3418 |
Clinical (unspecified phase) |
0.6573 |
Remote Similarity |
NPD2757 |
Phase 2 |
0.6573 |
Remote Similarity |
NPD3838 |
Phase 3 |
0.6567 |
Remote Similarity |
NPD6403 |
Clinical (unspecified phase) |
0.6567 |
Remote Similarity |
NPD6754 |
Phase 3 |
0.656 |
Remote Similarity |
NPD6750 |
Phase 2 |
0.6557 |
Remote Similarity |
NPD3083 |
Approved |
0.6542 |
Remote Similarity |
NPD1623 |
Approved |
0.6538 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.6538 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6531 |
Remote Similarity |
NPD6978 |
Phase 2 |
0.6531 |
Remote Similarity |
NPD6977 |
Clinical (unspecified phase) |
0.6529 |
Remote Similarity |
NPD7726 |
Phase 1 |
0.6526 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6526 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6525 |
Remote Similarity |
NPD3014 |
Clinical (unspecified phase) |
0.6525 |
Remote Similarity |
NPD3013 |
Phase 3 |
0.6525 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.6524 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6524 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.6522 |
Remote Similarity |
NPD5534 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD5802 |
Phase 2 |
0.6518 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6518 |
Remote Similarity |
NPD2062 |
Phase 2 |
0.6513 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.6507 |
Remote Similarity |
NPD3261 |
Phase 1 |
0.6498 |
Remote Similarity |
NPD3265 |
Phase 1 |
0.6494 |
Remote Similarity |
NPD5584 |
Clinical (unspecified phase) |
0.6488 |
Remote Similarity |
NPD6717 |
Clinical (unspecified phase) |
0.6483 |
Remote Similarity |
NPD7409 |
Clinical (unspecified phase) |
0.6483 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.6482 |
Remote Similarity |
NPD7856 |
Phase 2 |
0.6482 |
Remote Similarity |
NPD7857 |
Phase 3 |
0.648 |
Remote Similarity |
NPD3338 |
Clinical (unspecified phase) |
0.6476 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6475 |
Remote Similarity |
NPD6829 |
Phase 2 |
0.6475 |
Remote Similarity |
NPD6197 |
Approved |
0.6473 |
Remote Similarity |
NPD3811 |
Discontinued |
0.6471 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.6471 |
Remote Similarity |
NPD250 |
Approved |
0.6471 |
Remote Similarity |
NPD249 |
Approved |
0.6468 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6459 |
Remote Similarity |
NPD7851 |
Phase 1 |
0.6459 |
Remote Similarity |
NPD7850 |
Discontinued |
0.6457 |
Remote Similarity |
NPD1692 |
Approved |
0.6456 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD5018 |
Phase 3 |
0.6453 |
Remote Similarity |
NPD5425 |
Phase 1 |
0.6453 |
Remote Similarity |
NPD2130 |
Discontinued |
0.6453 |
Remote Similarity |
NPD4442 |
Phase 2 |
0.645 |
Remote Similarity |
NPD5116 |
Phase 1 |
0.6449 |
Remote Similarity |
NPD6976 |
Clinical (unspecified phase) |
0.6448 |
Remote Similarity |
NPD1480 |
Clinical (unspecified phase) |
0.6447 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6447 |
Remote Similarity |
NPD5428 |
Discontinued |
0.6446 |
Remote Similarity |
NPD6455 |
Phase 3 |
0.644 |
Remote Similarity |
NPD6760 |
Discontinued |
0.6435 |
Remote Similarity |
NPD3830 |
Phase 1 |
0.6435 |
Remote Similarity |
NPD4673 |
Phase 2 |
0.6435 |
Remote Similarity |
NPD1215 |
Discontinued |
0.6434 |
Remote Similarity |
NPD5878 |
Approved |
0.6434 |
Remote Similarity |
NPD5875 |
Approved |
0.6429 |
Remote Similarity |
NPD5172 |
Phase 2 |
0.6426 |
Remote Similarity |
NPD5627 |
Approved |
0.6423 |
Remote Similarity |
NPD1603 |
Discontinued |
0.642 |
Remote Similarity |
NPD5572 |
Phase 3 |
0.6419 |
Remote Similarity |
NPD5925 |
Phase 1 |
0.6419 |
Remote Similarity |
NPD4999 |
Phase 3 |
0.6419 |
Remote Similarity |
NPD4998 |
Phase 3 |
0.6417 |
Remote Similarity |
NPD2547 |
Discontinued |
0.6417 |
Remote Similarity |
NPD429 |
Approved |
0.6417 |
Remote Similarity |
NPD7188 |
Phase 3 |
0.641 |
Remote Similarity |
NPD2364 |
Suspended |
0.6409
|
Remote Similarity |
NPD6742 |
Phase 2 |